Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Sep;32(9):1689-1698.
doi: 10.1002/oby.24104. Epub 2024 Aug 7.

Gut-derived appetite hormones do not explain energy intake differences in humans following low-carbohydrate versus low-fat diets

Affiliations
Randomized Controlled Trial

Gut-derived appetite hormones do not explain energy intake differences in humans following low-carbohydrate versus low-fat diets

Aaron Hengist et al. Obesity (Silver Spring). 2024 Sep.

Abstract

Objective: The objective of this study was to explore how dietary macronutrient composition influences postprandial appetite hormone responses and subsequent energy intake.

Methods: A total of 20 adults (mean [SEM], age 30 [1] years, BMI 27.8 [1.3] kg/m2, n = 8 with normal weight, n = 6 with overweight, n = 6 with obesity) consumed a low-fat (LF) diet (10% fat, 75% carbohydrate) and a low-carbohydrate (LC) diet (10% carbohydrate, 75% fat) for 2 weeks each in an inpatient randomized crossover design. At the end of each diet, participants consumed isocaloric macronutrient-representative breakfast test meals, and 6-h postprandial responses were measured. Ad libitum energy intake was measured for the rest of the day.

Results: The LC meal resulted in greater mean postprandial plasma active glucagon-like peptide-1 (GLP-1; LC: 6.44 [0.78] pg/mL, LF: 2.46 [0.26] pg/mL; p < 0.0001), total glucose-dependent insulinotropic polypeptide (GIP; LC: 578 [60] pg/mL, LF: 319 [37] pg/mL; p = 0.0004), and peptide YY (PYY; LC: 65.6 [5.6] pg/mL, LF: 50.7 [3.8] pg/mL; p = 0.02), whereas total ghrelin (LC: 184 [25] pg/mL, LF: 261 [47] pg/mL; p = 0.0009), active ghrelin (LC: 91 [9] pg/mL, LF: 232 [28] pg/mL; p < 0.0001), and leptin (LC: 26.9 [6.5] ng/mL, LF: 35.2 [7.5] ng/mL; p = 0.01) were lower compared with LF. Participants ate more during LC at lunch (244 [85] kcal; p = 0.01) and dinner (193 [86] kcal; p = 0.04), increasing total subsequent energy intake for the day compared with LF (551 [103] kcal; p < 0.0001).

Conclusions: In the short term, endogenous gut-derived appetite hormones do not necessarily determine ad libitum energy intake.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Postprandial responses to isocaloric low carbohydrate (LC) or low fat (LF) meals following habituation to each diet in a randomized crossover design. Mean (range) of energy in the test meals was 777 (532 to 1043) kcal. Data are mean ± SEM. n=20. p-values from paired t-test of mean postprandial plasma concentrations. (A) active glucagon-like peptide-1 (GLP-1), (B) total glucose-dependent insulinotropic polypeptide (GIP), (C) peptide YY (PYY), (D) leptin, (E) total ghrelin, (F) active ghrelin.
Figure 2.
Figure 2.
Total energy intake (EI), and intake from lunch, dinner, and snacks throughout the day after isocaloric low carbohydrate (LC) or low fat (LF) meals following habituation to each diet in a randomized crossover design. Mean (range) of energy in the test meals was 777 (532 to 1043) kcal. Data are mean ± SEM and individual responses. n=20. p-values from paired t-test or Wilcoxon test. (A) Energy intake (kcal), (B) Relative Total EI as a proportion of 24h energy expenditure (24hEE), sedentary energy expenditure (SedEE), and sleeping energy expenditure (SEE), (C) Mass intake (g).
Figure 3.
Figure 3.
Comparisons between dietary macronutrient induced changes in gut hormone responses and pharmacological or bariatric surgery induced changes. (A) estimated mean active GLP-1 steady state average exposure concentrations, Cavg, achieved by low carbohydrate (LC) or low fat (LF) diet were orders of magnitude lower than the both oral and subcutaneous semaglutide using values from Overgaard et al. (B) peak active GLP-1 and PYY concentrations following a LC or LF test meal were orders of magnitude lower than peak concentrations observed during a mixed-meal test following Roux-en-Y Gastric Bypass surgery (RYGB) using data from Tan et al. For 3A, data are median ± 90% exposure ranges, for 3B, data are mean ± SEM.

Update of

Similar articles

Cited by

References

    1. Samms RJ, Goghlan MP, and Sloop KW (2020). How May GIP Enhance the Therapeutic Efficacy of GLP-1? Trends in Endocrinology and Metabolism 31, 410–421. 10.1016/j.tem.2020.02.006. - DOI - PubMed
    1. Sato T, Nakamura Y, Shiimura Y, Ohgusu H, Kangawa K, and Kojima M (2012). Structure, regulation and function of ghrelin. J Biochem 151, 119–128. 10.1093/jb/mvr134. - DOI - PubMed
    1. Tan T, Behary P, Tharakan G, Minnion J, Al-Najim W, Albrechtsen NJW, Holst JJ, and Bloom SR (2017). The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers. The Journal of clinical endocrinology and metabolism 102, 2364–2372. 10.1210/jc.2017-00469. - DOI - PMC - PubMed
    1. Holst JJ, Madsbad S, Bojsen-Moller KN, Svane MS, Jorgensen NB, Dirksen C, and Martinussen C (2018). Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss. Surg Obes Relat Dis 14, 708–714. 10.1016/j.soard.2018.03.003. - DOI - PMC - PubMed
    1. Troke RC, Tan TM, and Bloom SR (2014). The future role of gut hormones in the treatment of obesity. Ther Adv Chronic Dis 5, 4–14. 10.1177/2040622313506730. - DOI - PMC - PubMed

Publication types

LinkOut - more resources